Recombinant Erythropoietin and Analogues: A Challenge for Doping Control

Therapeutic Drug Monitoring

Volumn 26, Issue 2, 2004, Pages 175-179

  Pascual, José A ^a,b   Belalcazar, V ^a,b   De Bolos, C ^a   Gutierrez R ^a,b   Llop, E ^a,b   Segura, J ^a,b  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Detection; Doping; Erythropoietin

Indexed keywords

EPOADE; EPOMAX; EPOPEN; ERITROGEN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OLIGOSACCHARIDE; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN RECEPTOR;

CARBOHYDRATE ANALYSIS; CONFERENCE PAPER; DOPING; DRUG ABUSE; DRUG DETERMINATION; HEMATOCRIT; HUMAN; MUSCLE METABOLISM; OXYGENATION; PRIORITY JOURNAL; RETICULOCYTE; SPORT; URINALYSIS;

BIOLOGICAL MARKERS; DOPING IN SPORTS; ERYTHROPOIETIN, RECOMBINANT; GENE THERAPY; HUMANS; SUBSTANCE ABUSE DETECTION; TRANSFECTION;

EID: 14844301824     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200404000-00016     Document Type: Conference Paper

References (22)

1. Parisotto R, Gore CJ, Emslie KR, et al. A novel method utilizing markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. Haematologica. 2000;85:564-572.
2. Gore CJ, Parisotto R, Ashenden MJ, et al. Second-generation blood tests to detect erythropoietin abuse by athletes. Haematologica. 2003;88:333-344.
3. Lasne F, de Ceaurriz J. Recombinant erythropoietin in urine. Nature. 2000;405:635.
4. Lasne F, Martin L, Crepin C, et al. Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones. Anal Biochem. 2002;311:119-126.
5. Wide L, Bengtsson C, Berglund B, et al. Detection in blood and urine of recombinant erythropoietin administered to healthy men. Med Sci Sports Exerc. 1995;27:1569-1576.
6. Pascual JA, Lasne F, Howe C, et al. project for inter-laboratory comparison of the method for the detection of rhEPO in human urine. Results, conclusions and current status. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U, eds. Recent Advances in Doping Analysis (10). Köln: Sport und Buch Straub, 2002:135-144.
7. Egrie JC, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Nephrol Dial Transplant. 2001;16(Suppl 3):3-13.
8. Kochendoerfer GG, Chen SY, Mao F, et al. Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis protein. Science. 2003;299:884-887.
9. Wells JA. Hormone mimicry. Science. 1996;273:449-463.
10. Barbone FP, Johnson DL, Farrel FX, et al. New epoetin molecules and novel therapeutic approaches. Nephrol Dial Transplant. 1999;14(suppl 2):80-84.
11. Biazzo DE, Motamedi H, Mark DF, et al. A high-throughput assay to identify compounds that can induce dimerization of the erythropoietin receptor. Anal Biochem. 2000;278:39-45.
12. Goldberg J, Jin Q, Ambroise Y, et al. Erythropoietin mimetics derived from solution phase combinatorial libraries. J Am Chem Soc. 2002;124:544-555.
13. 3 in induction of erythroid progenitor cell proliferation. Exp Hematol. 2002;30:403-409.
14. Dalle B, Henri A, Rouyer-Fessard P, et al. Dimeric erythropoietin fusion protein with enhanced erythropoietic activity in vitro and in vivo. Blood. 2001;97:3776-3782.
15. Richard RE, Blau CA. Small-molecule-directed Mp1 signaling can complement growth factors to selectively expand genetically modified cord blood cells. Stem Cells. 2003;21:71-78.
16. Adam L. Gene therapy may be up to speed for cheats at 2008 Olympics. Nature. 2001;414:569.
17. Cavazzana-Calvo M, Hacein-Bey S, Yates F, et al. Gene therapy of severe combined immunodeficiencies. J Gene Med. 2001;3:201-206.
18. Smith L, Byers JF. Gene therapy in the post-Gelsinger era. JONASHealth Law Ethics Regul. 2002;4:104-110.
19. IOC Gene Therapy Symposium on "Gene therapy and its future impact on sport," Lausanne, 6 June 2001.
20. WADA Conference on "Genetic Enhancement of Athletic Performance," New York, 18-20 March 2002.
21. Wadler GI. Future and designer drugs: emerging science and technology. In: Bahrke MS, Yeaslis CE, eds. Performance Enhancing Substances in Sport and Exercise. Champaign, IL: Human Kinetics, 2002:305-321.
22. Johnston J, Tazelaar J, Rivera VM, et al. Regulated expression of erythropoietin from AAV vector safely improves the anemia of β-thalassemia in a mouse model. Mol Ther. 2003;7:493-497.